Browse Subject Areas

Click through the PLOS taxonomy to find articles in your field.

For more information about PLOS Subject Areas, click here.

  • Loading metrics

Haplotype CGC from XPD, hOGG1 and ITGA2 polymorphisms increases the risk of nasopharyngeal carcinoma in Malaysia

  • Eng-Zhuan Ban,

    Roles Conceptualization, Data curation, Formal analysis, Investigation, Methodology, Writing – original draft

    Affiliation Department of Community Health, Faculty of Medicine and Health Sciences, Universiti Putra Malaysia, Serdang, Malaysia

  • Munn-Sann Lye ,

    Roles Conceptualization, Data curation, Formal analysis, Funding acquisition, Investigation, Methodology, Project administration, Supervision, Writing – original draft, Writing – review & editing

    Affiliation Department of Community Health, Faculty of Medicine and Health Sciences, Universiti Putra Malaysia, Serdang, Malaysia


  • Pei Pei Chong,

    Roles Conceptualization, Methodology

    Affiliation Department of Biomedical Science, Faculty of Medicine and Health Sciences, Universiti Putra Malaysia, Serdang, Malaysia

  • Yoke-Yeow Yap,

    Roles Investigation, Resources

    Affiliation Department of Otorhinolaryngology, Faculty of Medicine and Health Sciences, Universiti Putra Malaysia, Serdang, Malaysia

  • Siew Ying Crystale Lim,

    Roles Conceptualization, Formal analysis, Methodology

    Affiliation Faculty of Applied Sciences, UCSI University, Cheras, Malaysia

  • Hejar Abdul Rahman

    Roles Conceptualization, Funding acquisition, Resources

    Affiliation Department of Community Health, Faculty of Medicine and Health Sciences, Universiti Putra Malaysia, Serdang, Malaysia

Haplotype CGC from XPD, hOGG1 and ITGA2 polymorphisms increases the risk of nasopharyngeal carcinoma in Malaysia

  • Eng-Zhuan Ban, 
  • Munn-Sann Lye, 
  • Pei Pei Chong, 
  • Yoke-Yeow Yap, 
  • Siew Ying Crystale Lim, 
  • Hejar Abdul Rahman



8-oxoG, a common DNA lesion resulting from reactive oxygen species (ROS), has been shown to be associated with cancer initiation. hOGG1 DNA glycosylase is the primary enzyme responsible for excision of 8-oxoG through base excision repair (BER). Integrins are members of a family of cell surface receptors that mediate the cell-cell and extracellular matrix (ECM) interactions. Integrins are involved in almost every aspect of carcinogenesis, from cell differentiation, cell proliferation, metastasis to angiogenesis. Loss of ITGA2 expression was associated with enhanced tumor intravasation and metastasis of breast and colon cancer. XPD gene encodes DNA helicase enzyme that is involved in nucleotide excision repair (NER). It is shown in previous research that XPD homozygous wildtype Lys/Lys genotype was associated with higher odds of NPC.


We conducted a 1 to N case-control study involving 300 nasopharyngeal carcinoma (NPC) cases and 533 controls matched by age, gender and ethnicity to investigate the effect of hOGG1 Ser326Cys, ITGA2 C807T and XPD Lys751Gln polymorphisms on NPC risk. Linkage disequilibrium and haplotype analysis were conducted to explore the association of allele combinations with NPC risk. Restriction fragment length polymorphism (RFLP-PCR) was used for DNA genotyping.


No significant association was observed between hOGG1 Ser326Cys and ITGA2 C807T polymorphisms with NPC risk after adjustment for age, gender, ethnicity, cigarette smoking, alcohol and salted fish consumption. Lys/Lys genotype of XPD Lys751Gln polymorphism was associated with increased NPC risk (OR = 1.60, 95% CI = 1.06–2.43). Subjects with history of smoking (OR = 1.81, 95% CI = 1.26–2.60), and salted fish consumption before age of 10 (OR = 1.77, 95% CI = 1.30–2.42) were observed to have increased odds of NPC. The odds of developing NPC of CGC haplotype was significantly higher compared to reference AGC haplotype (OR = 2.20, 95% CI = 1.06–4.58).


The allele combination of CGC from hOGG1, ITGA2 and XPD polymorphisms was significantly associated with increased odds of NPC.


Nasopharyngeal carcinoma (NPC) develops commonly in the Fossa of Rosenmuller of the nasopharynx. It is a rare malignancy in most parts of the world with an annual frequency less than 1 per 100 000 population [1]. Certain populations such as Chinese living in Guangdong province of Mainland China and Southeast Asia as well as natives from Arctic region (Alaska and Greenland) experience a much higher NPC risk compared to the rest of the world [2]. NPC is the 4th most common cancer in Malaysia in 2007 [3]. Given the increasing incidence of NPC cases and the fact that many cases are diagnosed at an advanced stage [4], it is important to find ways of ensuring early diagnosis and prompt treatment. This is challenging as the nasopharynx is not easily visualized and accessed. Discovering biomarkers for NPC screening is one of the ways in which a susceptible population could be identified early, which will help physicians in early detection and treatment of NPC.

Several environmental factors have been shown to be consistently associated with NPC. EBV infection [5], consumption of salted fish at an early age [67] (possibly due to nitrosamines mutagenicity), prolonged occupational exposure to wood dust [8] and long-term cigarette smoking [9] are examples of risk factors implicated in NPC carcinogenesis. In addition, normal cellular metabolic processes are also capable of producing hydroxyl radicals that can cause oxidative damage to DNA [10]. Oxidative stress has been linked to increased cancer risk via reactive oxygen species (ROS) acting in different stages of tumorigenesis [11]. One common mutagenic by-product resulting from oxidative damage is 8-oxo-7,8-dihydroguanine (8-oxoG), which is a G:C to T:A transversion causing agent [12]. Human 8-oxoguanine DNA glycosylase 1 (hOGG1) is the primary enzyme responsible for excision of 8-oxoG through base excision repair (BER). Short-patch BER removes 8-oxoG through the action of DNA glycosylase and AP lyase followed by the re-synthesis of DNA by DNA polymerase β. DNA is ligated by DNA ligase III eventually to complete the repair [13]. hOGG1 protein initiates BER via its ability to identify the damaged base. The presence and functionality of hOGG1 protein affects the level of BER activity directly. Several studies on association of hOGG1 Ser326Cys polymorphism with various cancers demonstrated that hOGG1-Cys326 conferred higher risk of cancer [1417]. However, a study conducted in a Chinese population suggested otherwise with hOGG1-Ser326 conferring increased cancer risk instead [18]. Similarly for NPC, studies from different countries showed inconsistent results. Cho et al [19] demonstrated that Ser/Cys and Cys/Cys genotypes of hOGG1 gene (Ser326Cys) is associated with altered risk of NPC (OR = 1.6, 95% CI = 1.0–2.6). Laantri et al however showed that neither Ser/Cys nor Cys/Cys genotypes of hOGG1 gene (Ser326Cys) were significantly associated with NPC risk (OR = 1.22, 95% CI = 0.77–1.90) [20].

Xeroderma pigmentosum group D (XPD) gene encodes for 5’-3’ DNA helicase enzyme that is involved in transcription factor IIH (TFIIH) complex of nucleotide excision repair (NER) [21]. TFIIH is mainly made up of 2 sub-complexes which are the core and cdk-activating kinase (CAK) complex [22]. 6 sub-units namely XPB, p62, p52, p44, p34 and p8 combined to form the core whereas another 3 sub-units cdk7, cdk-activating kinase assembly factor I (MATI) and cyclin H bound to form CAK complex [22]. The remaining component XPD physically bridges 2 sub-complexes together to form a functional TFIIH complex [2324]. TFIIH complex is responsible for the dual-incision process in NER that helps to unwind the DNA at the damaged region [25]. Deficient XPD-p44 interaction results in impaired unwinding of DNA in NER due to sub-optimal helicase activity [26]. XPD Lys751Gln polymorphism is located in carboxy terminal domain (CTD) where XPD-p44 interaction takes place [27]. XPD homozygous wildtype Lys/Lys genotype has been shown to be associated with higher odds of NPC (OR = 1.58, 95% CI = 1.05–2.38, p = 0.028) [28].

Integrins are members of a family of cell surface receptors that mediate the cell-cell and cell-extracellular matrices (ECM) interactions [29]. It has been demonstrated that integrins played an important role in apoptosis [29], tumor angiogenesis [30] and metastasis [31]. Integrins are heterodimeric and consist of 2 transmembrane glycoproteins (α and β) that are non-covalently bound together [32]. Thus far, there are 16 α and 8 β subunits in the integrin family that combine and produce more than 22 different αβ cell surface receptors [32]. Integrin α2 is an important collagen receptor that is mainly expressed on platelets and epithelial cells [33]. Under normal cell differentiation, expression of ITGA2 is regulated and kept within normal range but its over-expression is associated with decreased tumor cells motility and invasiveness [3436]. Loss of ITGA2 in cancer cells is associated with metastasis in breast and colon carcinoma [33, 37]. ITGA2 C807T polymorphism is a silent nucleotide change in position 807 (TTC/TTT, rs1126643) which resulted in no amino acid change. Recent studies have indicated that ITGA2 C807T polymorphism was associated with increased risk of various cancers namely colorectal and breast carcinoma [3839].

We describe results from a matched case-control study investigating the effect of hOGG1 Ser326Cys, ITGA2 C807T and XPD Lys751Glu polymorphisms on the risk of NPC.

Materials and methods

The study was approved by the Medical Research Ethics Committee of the Ministry of Health Malaysia (NMRR-11-1038-10007). Written informed consent was obtained from all research participants involved in this study. We assumed the exposure rate of hOGG1 Ser326Cys polymorphism in controls at 61% [19] and estimated that this polymorphism could increase NPC risk by 100%. Using the formula adopted by Schlesselman [40] on matched case-control study, with two sided alpha level of 0.05, 196 matched pairs were needed to attain a power of 90% to detect a 100% increase in NPC risk in the proportion of patients with hOGG1 Ser326Cys polymorphism. 300 histologically confirmed NPC cases and 533 healthy controls were recruited from two public hospitals in this study. For NPC cases, the inclusion criteria were histologically confirmed NPC patients who were diagnosed from the year 2008 onwards. NPC cases who were 18 years of age and below at the time of recruitment were excluded. The inclusion criteria for healthy controls were individuals that have resided in Malaysia for at least 5 years and without having had a history of cancer. All controls were matched to the cases by age (±3 years), gender and ethnicity. Personal information on demographic factors, smoking status, alcohol and salted fish consumption were collected at recruitment. Smoking status and alcohol consumption were divided into 2 categories: never/ever smoked and never/ever consumed alcohol. For salted fish consumption, classification used was never/ever consumed salted fish at age of 10.

DNA extraction and storage

2 ml of venous blood was obtained from every research subject. Fresh blood was immediately placed into an EDTA coated vacutainer. Filled EDTA tube was stored on ice and transferred back on the same day to the laboratory in the university to be processed. DNA was extracted from the blood using QIAamp® DNA mini kit (QIAGEN, Venlo, Netherlands) and immediately stored in minus 20°C freezer until further use.

DNA genotyping

hOGG1 Ser326Cys (rs1052133), ITGA2 C807T (rs1126643) and XPD Lys751Gln (rs13181) polymorphisms were assessed by using RFLP-PCR (Restriction Fragment Length Polymorphism). Sequence of forward and reverse primers used in DNA genotyping are listed in Table 1. Outcome of the PCR for the XPD, hOGG1 and ITGA2 genotyping were products of 302 bp, 184 bp and 115 bp respectively. The details on PCR composition, PCR condition and RFLP digestion are listed in Table 2. For each polymorphism, there were 3 possible results depending on the subject’s genotype (Fig 1). In the case of XPD, samples were identified as homozygous Lys/Lys if the results showed full digestion with 102 bp and 82 bp product. Homozygous Gln/Gln samples showed only single PCR product that was 184 bp in size. All 3 products of different sizes were observed for heterozygous Lys/Gln. For hOGG1, homozygous Ser/Ser showed only a single 302bp product while homozygous Cys/Cys was fully digested into 2 different products that were 186 bp and 116 bp in size. All 3 products of different sizes were observed for heterozygous Ser/Cys. For ITGA2, homozygous CC was fully digested into 2 products that were 92 bp and 23 bp in size. For homozygous TT, no digestion occurred and only a single 115 bp product was visible. All 3 products of different sizes were observed for heterozygous CT. For quality control, 10% of the total PCR products were sent for DNA sequencing to confirm the results of RFLP-PCR.

Table 1. Sequence of forward and reverse primers used in DNA genotyping.

Table 2. Details on PCR composition, PCR condition and RFLP digestion of XPD, hOGG1 and ITGA2 polymorphism.

Fig 1. Gel electrophoresis of PCR-RFLP products for representative blood samples for the hOGG1 Ser326Cys polymorphism.

Lane M represents 100bp DNA ladder marker (QIAgen), lanes 1 represents positive control (RFLP reaction with genotype-known PCR product), lanes 3 represents Ser/Ser genotype (302bp), lanes 2, 5, 6, 8 and 10–13 represent Ser/Cys genotype (302bp, 186bp and 116bp), lanes 4, 7 and 9 represent Cys/Cys genotype (186bp and 116bp), lane 14 represents negative controls (RFLP reaction without PCR product) and lane 15 represents negative control (RFLP reaction without PCR product but with restriction enzyme, Fnu4H1).

Statistical analysis

Relative frequencies were used to describe variables studied including socio-demographic and exposure data using SPSS version 21. Deviation from Hardy Weinberg equilibrium (HWE) was tested using Court Lab Calculator on controls [41]. Conditional logistic regression (STATA 10) was used to estimate adjusted odds ratio (ORs) and 95% confidence interval (CI) for NPC risk comparing variants of hOGG1 and ITGA2 polymorphisms with wild type, controlling for cigarette smoking, alcohol and salted fish consumption. Co-dominant model is used in the estimation of odds ratio. A p-value less than 0.05 was considered as statistically significant. Linkage disequilibrium (LD) of the 3 loci, haplotypes and their frequencies as well as association with NPC risks were determined by using web-based SNPstats software [42].


Characteristics of study population

A total of 300 cases of histologically confirmed NPC and 533 healthy controls were available for analysis in present study. The demographic and exposure data are shown in Table 3. The average age of cases and controls was 52.8 and 53.6 years respectively. Male to female ratio for both cases and controls was 3:1. Of 300 cases, 213 (71.0%) cases were of Chinese origin, 84 (28.0%) cases were of Malay origin, and the remaining 3 (1.0%) cases were classified under other origins. Of the 533 controls, 378 (70.9%) were of Chinese origin, 150 (28.1%) controls were of Malay origin and the remaining 5 (1.0%) controls were classified under other origins.

NPC patients were more likely to ever consume salted fish at 10 years of age compared to controls (OR = 1.77, 95% CI = 1.30–2.42). Study participants with previous smoking history were more likely to develop NPC (OR = 1.81, 95% CI = 1.26–2.60). There was no significant difference observed in NPC susceptibility between study subjects who ever consumed alcohol with those who never (OR = 1.41, 95% CI = 0.97–2.06).

Genotypic distribution of XPD Lys751Gln (rs13181), hOGG1 Ser326Cys (rs1052133) and ITGA2 C807T (rs1126643) polymorphisms

Genotypic frequencies of controls were in Hardy Weinberg Equilibrium for all 3 polymorphisms as shown in Table 4. 100% concordance was achieved between results from RFLP-PCR assay and the 10% samples sent for DNA sequencing. No significant association was observed between hOGG1 Ser326Cys and ITGA2 polymorphisms and odds of developing NPC. After adjusting for age, gender, ethnicity, cigarette smoking, alcohol consumption and salted fish consumption at age of 10 years, the OR for NPC comparing Ser/Cys and Cys/Cys genotype to wild type Ser/Ser were 1.21 (0.80–1.83) and 1.16 (0.74–1.81) respectively as shown in Table 5. For ITGA2, OR for NPC risks comparing between CT and TT genotypes to wildtype CC were 0.75 (0.54–1.03) and 0.85 (0.49–1.45) respectively (Table 5). XPD Lys751Gln polymorphism was significantly associated with NPC risk. The odds of developing NPC for genotype Lys/Lys was 1.60 (1.06–2.43) when compared to Lys/Gln and Gln/Gln as reference (Table 5).

Table 4. Allelic and genotypic frequencies of hOGG1 Ser326Cys (rs1052133), ITGA2 C807T (rs1126643) and XPD Lys751Gln (rs13181) polymorphism (Hardy-Weinberg Equilibrium test).

Table 5. Association of polymorphisms with risk of NPC in the study population controlling for smoking, alcohol and salted fish consumption at the age of 10.

Linkage disequilibrium and haplotype analysis of XPD Lys751Gln (rs13181), hOGG1 Ser326Cys (rs1052133) and ITGA2 C807T (rs1126643) polymorphisms

As it is shown in Table 6, none of the aforementioned polymorphisms were observed to be non-randomly co-inherited. Calculated D’ value between polymorphisms was close to 0 which suggested that these polymorphisms were co-inherited as a random and non-selective event. Frequencies of different combinations of haplotypes in NPC cases and controls are given in Table 7. Haplotype CGC was observed to be significantly associated with NPC risk (OR = 2.20, 95% CI = 1.06–4.58) using the most frequent allele combination AGC as reference after adjustment for age, gender, ethnicity, cigarette smoking, alcohol intake and salted fish consumption at age of 10.

Table 6. Linkage disequilibrium between hOGG1 Ser326Cys, ITGA2 C807T and XPD Lys751Glu polymorphisms (D’).

Table 7. Frequency distribution of haplotypes in NPC cases and controls and association with NPC risk.


Cigarette smoking and salted fish consumption at age of 10 were associated with increased odds of NPC. Other studies reported similar results [4344] and hence, our results further corroborate the presumptive causal role of these environmental factors in NPC carcinogenesis. Independently of genetic factors, these habit and environmental factors (cigarette smoking and salted fish consumption) produced higher odds ratios than the SNPs indicating that the contribution of these factors to the risk of NPC could be greater than genetic factors; this is also reflected in the logit model (Table 5). We found no synergistic effect between the genotypes and environmental factors, only an additive effect. Cigarette smoking-related carcinogens including polycyclic aromatic hydrocarbons (PAH) and N-nitrosamines have been shown to cause bulky DNA adducts [45]. Failure in removing the aforementioned carcinogens from the body is postulated to increase risk of developing various cancers, namely lung, colorectal and oesophageal cancers [4648].

The genotype distributions of hOGG1 Ser326Cys polymorphism in our study are similar to those reported by Wu et al [49]. Ser/Ser, Ser/Cys and Cys/Cys frequencies in our controls were 18.9%, 50.7% and 30.4% respectively compared with 16.0%, 49.0% and 35.0%, respectively from the Chinese study. For ITGA2, frequency of CC, CT and TT reported by Chen et al [50] were 50.7%, 40.3% and 9.0% respectively compared to 52.5%, 39.0% and 8.5% in our series. However, no significant relationship was found between both hOGG1 Ser326Cys and ITGA2 C807T polymorphisms with odds of NPC. A significant association was found between XPD Lys751Gln polymorphism and the odds of NPC. The effect of this individual polymorphism has been discussed extensively in our previous publication [28].

Haplotype analysis using SNPStats software revealed that allele combination CGC (XPD-Gln751/hOGG1-Cys326/ITGA2-C807) (OR = 2.20, 95% CI = 1.06–4.58) conferred higher risk of NPC using haplotype AGC as reference. The main difference between the haplotype CGC and AGC (reference) is the XPD-Gln751 allele. Previous studies have indicated that XPD-Gln751 variant was associated with several cancers, namely chronic myeloid leukaemia (CML) [51], oesophageal squamous cell carcinoma [52], digestive tract cancer [52], and hepatocellular carcinoma [53]. Apart from conferring cancer risk by itself, XPD-Gln751 allele was also shown in the other studies that it increases cancer risk in combination with other DNA repair genes. For example, Zhou et al have shown a significantly increased lung cancer risk in subjects carrying at least 5 variant alleles of XPD Asp312Asn, Lys751Gln and XRCC1 Arg399Gln polymorphisms compared to subjects with no variant allele [54]. In another study, Chen et al reported that increased lung cancer risk was observed in patients carrying variant alleles for both XPD Lys751Gln and XRCC1 Arg194Trp compared to patients with only 1 variant allele in the Chinese population [55]. Besides conferring higher cancer risk, XPD Lys751Gln polymorphism was shown in past studies to be associated with p53 gene mutation [5556]. Mechanic et al found an interaction between the XPD variant alleles (Asn312 and Gln751) and the TP53 Pro72 allele for TP53 mutations [57]. XPD is a component of p53-mediated apoptosis pathway and both proteins interact directly via CTD region of XPD, where Lys751Gln is located [58]. Fibroblasts from patients with germ-line XPD mutation produce attenuated p53-mediated apoptosis, further substantiating the role of XPD in mediating cell death [59]. On the other hand, a higher risk of p53 mutation was observed in subjects with APE1 Asp/Asp plus hOGG1-Cys326 than in those carrying APE1-Glu plus hOGG1 Ser/Ser (OR = 3.72; 95% CI = 1.33–10.40) [60]. Given the fact that p53 tumor suppressor gene encodes for an important protein that induces growth arrest, DNA repair or cell death in response to DNA damage [6162], inhibition of the p53 protein via mutation is an important event in early onset of carcinogenesis. Various DNA tumor viruses encode transforming oncoproteins that interact with p53 and initiate carcinogenesis through inhibition of p53-dependent programmed cell death [63]. Cells lacking functional p53 protein showed defective repair of UV damage [64]. Research using host cell reactivation (HCR) assay reported that cells with wild-type p53 showed a 3-fold higher reactivation level compared to its mutant counterpart [65].

Expression of α2β1 integrin on the platelet surface is lower in subjects carrying 807C compared to 807T allele of ITGA2 [66]. Results from an in-vitro study reported that α2 null tumor cells demonstrated enhanced anchorage-independent growth [35]. Re-expression of α2β1 in tumor cells has been reported to exhibit inhibitory effect on anchorage-independent growth of these tumor cells [67]. We postulate that the amino acid change from lysine to glutamine in XPD codon 751 decreases binding between p53 and XPD protein resulting in attenuated p53-mediated apoptosis, and hence, increasing chances of immortality for DNA damaged cells [68]. In addition, hOGG1-Cys326 allele tends to increase rate of p53 mutation [60] leading to a deficiency in p53-dependent apoptosis and DNA repair. Loss of α2 integrin expression due to the base change from C to T in codon 807 [66] might allow β1 integrin to contribute to cancer development through its binding with other α integrins, namely α5β1 in particular. Ligation of α5β1 to fibronectin was shown to constantly suppress apoptosis in an in-vitro study [69] and increased expression of proto-oncogene Bcl-2 (cell death antagonist) was observed as a result of integrin α5β1 ligation [70]. Therefore, effect of the interaction among 3 genes namely XPD-Gln751, hOGG1-Cys326 and ITGA2-C807 (haplotype CGC) could be synergistic. Attenuated p53-dependent apoptosis and upregulation of proto-oncogene Bcl-2 resulting from the aforementioned interaction could be the key to the increased NPC risk.

Although the present results may be applicable only to the Malaysian population, Malaysia—in particular peninsula Malaysia where the study was done—has a representation of 3 major ethnic groups with Malays forming the majority, comprising 68.6% of the population, followed by Chinese (23.4%) and Indians (7.0%) [71]. With different genetic pools in the study sample reflecting some of the major ethnic groups in the Malay Archipelago and the Asian continent, this study population constitutes an appropriate population for molecular epidemiological association studies. In addition, Malaysia has a sizeable minority population of Chinese origin. Given the higher NPC susceptibility of individuals of Chinese origin, and the fact that the incidence of NPC among male Malaysian Chinese is among the highest globally, results from the current study constitute a major contribution to the knowledge pool on NPC. Hence, if hOGG1 Ser326Cys, ITGA2 C807T and XPD Lys751Gln polymorphisms from the current study are verified to be valid diagnostic markers for NPC patients, the possibility exists for customizing screening modalities for high risk individuals, such as those with a family history of NPC. Since only 3% of NPC patients carry this high risk haplotype block CGC the application of hOGG1 Ser326Cys, ITGA2 C807T and XPD Lys751Gln as a diagnostic marker in a mass preventive screening program appears to be unfeasible. However, if other researchers can replicate and validate findings from the present study, the haplotype block CGC could potentially be clinically useful as a supplementary test for targeted high risk populations.

In conclusion, the allele combination CGC was significantly associated with NPC risk. Interactions between the 3 polymorphisms need to be further investigated to provide evidence for a potentiating effect among them. Other genes in the BER and NER mechanisms involved in cancer initiation should be studied to better understand NPC carcinogenesis.

Supporting information

S1 Appendix. Algorithm predicting the risk of NPC including both the environmental and genetic variables.


S1 Table. Tables of logistic regression output involving analyses on the risk of NPC in different strata (smoking and non-smoking).


S2 Table. Tables of analyses involving three genetic models (dominant, recessive and additive) for the association of hOGG1 Ser326Cys and ITGA2 C807T on the risk of NPC.


S1 Text. Justifications on the selection of three specific genetic markers (hOGG1 Ser326Cys, ITGA2 C807T & XPD Lys751Gln).



The authors are grateful to all hospital staff involved as well as the data enumerators, research assistants and participants who assisted in this study. This study was funded by the Ministry of Science, Technology and Innovation (MOSTI; Project code: 04-11-08-625FR).


  1. 1. Chou J, Lin YC, Kim J, You L, Xu Z, He B, et al. (2008) Nasopharyngeal Carcinoma—Review of the molecular mechanisms of tumorigenesis. Head Neck. 30 (7):946–963. [published Online First: 29 April 2008]. pmid:18446839
  2. 2. Yu MC and Yuan JM. (2002) Epidemiology of nasopharyngeal carcinoma. Semin Cancer Biol. 12(6):421–9 [published Online First: 19 November 2002]. pmid:12450728
  3. 3. O Zainal Ariffin and I.T Nor Saleha. (2011) NCR Report 2007, Ministry of Health, Malaysia.
  4. 4. Lee AW, Foo W, Law SC, Poon YF, Sze WM, O SK, et al. (1997) Nasopharyngeal carcinoma: presenting symptoms and duration before diagnosis. Hong Kong Med J. 3(4):355–361. pmid:11847385
  5. 5. Raab-Traub N. (2002) Epstein-Barr virus in the pathogenesis of NPC. Semin Cancer Biol. 12(6):431–41 [published Online First: 19 November 2002]. pmid:12450729
  6. 6. Ning JP, Yu MC, Wang QS, Henderson BE. (1990) Consumption of salted fish and other risk factors for nasopharyngeal carcinoma (NPC) in Tianjin, a low-risk region for NPC in the People’s Republic of China. J Natl Cancer Inst. 82(4):291–6. pmid:2299678
  7. 7. Yu MC, Ho JHC, Lai SH and Henderson BE. (1986) Cantonese-style salted fish as a cause of nasopharyngeal carcinoma: report of a case-control study in hong Kong. Cancer Res. 46:956–961. pmid:3940655
  8. 8. Hildesheim A, Dosemeci M, Chan CC, Chen CJ, Cheng YJ, Hsu MM, et al. (2001) Occupational exposure to wood, formaldehyde, and solvents and risk of nasopharyngeal carcinoma. Cancer Epidemiol Biomarkers Prev. 10(11):1145–53. pmid:11700262
  9. 9. Chow WH, Mclaughlin JK, Nam JM and Blot WJ. (1993) Tobacco use and nasopharyngeal carcinoma in a cohort of U.S. veterans. Int. J. Cancer. 55:538–540. pmid:8406978
  10. 10. Demple B and Harrison L. (1994) Repair of oxidative damage to DNA: enzymology and biology. Annu Rev Biochem. 63:915–948. pmid:7979257
  11. 11. Reuter S, Gupta SC, Chaturvedi MM, Aggarwal BB. (2010) Oxidative stress, inflammation and cancer: How are they linked? Free Radic Biol Med. 49(11):1603–16 [published Online First: 16 September 2010]. pmid:20840865
  12. 12. Cheng KC, Cahill DS, Kasai H, Nishimura S, Loeb LA. (1992) 8-hydroxyguanine, an abundant form of oxidative DNA damage, causes G-T and A-C substitutions. J Biol Chem. 267:166–172. pmid:1730583
  13. 13. Boiteux S and Radicella JP. (2000) The human OGG1 gene: structure, functions, and its implication in the process of carcinogenesis. Arch Biochem Biophys. 377(1):1–8. pmid:10775435
  14. 14. Yuan T, Wei J, Luo J, Liu M, Deng S, Chen P. (2012) Polymorphisms of base-excision repair genes hOGG1 326Cys and XRCC1 280His increase hepatocellular carcinoma risk. Dig Dis Sci. 57:2451–7 [published Online First: 8 May 2012]. pmid:22565339
  15. 15. Xie H, Xia Kai, Rong H, Chen X. (2013) Genetic polymorphism in hOGG1 is associated with triple-negative breast cancer risk in Chinese Han women. The Breast. 22(5):707–712 [published Online First: 29 January 2013]. pmid:23369609
  16. 16. Ni M, Qiu J, He W, Wang X. (2012) The functional Ser326Cys polymorphism in hOGG1 is associated with gastric cancer risk: evidence from 1180 cases and 2444 controls. Eur J Gastroenterol Hepatol. 24(6):683–7. pmid:22343785
  17. 17. Elahi A, Zheng Z, Park J, Eyring K, McCaffrey T, Lazarus P. (2002) The human OGG1 DNA repair enzyme and its association with orolaryngeal cancer risk. Carcinogenesis. 23(7):1229–34 pmid:12117782
  18. 18. Ma L, Chu H, Wang M, Shi D, Zhong D, Li P, et al. (2012) hOGG1 Ser326Cys polymorphism is associated with risk of bladder cancer in a Chinese population: a case control study. Cancer Science. 103(7):1215–20 [published Online First: 7 May 2012]. pmid:22463382
  19. 19. Cho EY, Hildesheim A, Chen CJ, Hsu MM, Chen IH, Mittl BF, et al. (2003) Nasopharyngeal carcinoma and genetic polymorphisms of DNA repair enzymes XRCC1 and hOGG1. Cancer Epidemiol Biomarkers Prev. 12(10):1100–4. pmid:14578150
  20. 20. Laantri N, Jalbout M, Khyatti M, Ayoub WB, Dahmoul S, Ayad M, et al. (2011) XRCC1 and hOGG1 genes and risk of nasopharyngeal carcinoma in North African countries. Mol Carcinog. 50(9):732–7 [published Online First: 22 April 2011]. pmid:21520294
  21. 21. Sung P, Bailly V, Weber C, Thompson LH, Prakash L, Prakash S. (1993) Human xeroderma pigmentosum group D gene encodes a DNA helicase. Nature. 365:852–855. pmid:8413672
  22. 22. Lainé JP, Mocquet V, Egly JM. (2006) TFIIH enzymatic activities in transcription and nucleotide excision repair. Methods Enzymol. 408:246–263. pmid:16793373
  23. 23. Liu H, Rudolf J, Johnson KA, McMahon SA, Oke M, Carter L, et al. (2008) Structure of the DNA repair helicase XPD. Cell. 133: 801–812. pmid:18510925
  24. 24. Abdulrahman W, Iltis I, Radu L, Braun C, Maglott-Roth A, Giraudon C, et al. (2013) ARCH domain of XPD, an anchoring platform for CAK that conditions TFIIH DNA repair and transcription activities. Proc Natl Acad Sci USA. 110(8): E633–E642. pmid:23382212
  25. 25. Sancar A. (1994) Mechanisms of DNA excision repair. Science. 266: 1954–1956. pmid:7801120
  26. 26. Kuper J, Braun C, Elias A, Michels G, Sauer F, Schmitt DR, et al. (2014) In TFIIH, XPD Helicase Is Exclusively Devoted to DNA Repair. PLoS Biol. 12(9): e1001954. pmid:25268380
  27. 27. Fan L, Fuss JO, Cheng QJ, Arvai AS, Hammel M, Roberts VA, et al. (2008) XPD Helicase Structures and Activities: Insights into the Cancer and Aging Phenotypes from XPD Mutations. Cell. 133(5): 789–800. pmid:18510924
  28. 28. Lye MS, Visuvanathan S, Chong PP, Yap YY, Lim CC, Ban EZ. (2015) Homozygous Wildtype of XPD K751Q Polymorphism Is Associated with Increased Risk of Nasopharyngeal Carcinoma in Malaysian Population. PLoS One. 10(6):e0130530. pmid:26086338
  29. 29. Anderson LR. Owens TW, Naylor MJ. (2014) Integrins in development and cancer. Biophys Rev. 6:191–202. pmid:28510181
  30. 30. Rathinam R, Suresh KA. (2010) Important role of integrins in the cancer biology. Cancer Metastasis Rev. 29:223–237. pmid:20112053
  31. 31. Barbara GS, Judith AV. (2008) Roles of integrins in tumor angiogenesis and lymphangiogenesis. Lymphat Res Biol. 6(3–4):155–163. pmid:19093788
  32. 32. Clezardin P. (1998) Recent insights into the role of integrins in cancer metastasis. Cell Mol Life Sci. 54:541–548. pmid:9676573
  33. 33. Ding W, Fan XL, Xu X, Huang JZ, Xu SH, Geng Q, et al. (2015) Epigenetic silencing of ITGA2 by MiR-373 promotes cell migration in breast cancer. PLoS One. 10(8):e0135128. pmid:26258411
  34. 34. Pan H, Wanami LS, Dissanayake TR, Bachelder RE. (2009) Autocrine semaphorin3A stimulates alpha2 beta1 integrin expression/function in breast tumor cells. Breast Cancer Res Treat. 118(1):197–205. pmid:18787945
  35. 35. Ramirez NE, Zhang Z, Madamanchi A, Boyd KL, O’Rear LD, Nashabi A, et al. (2011) The α2β1 integrin is a metastasis suppresor in mouse models and human cancer. J Clin Invest. 121(1): 226–237. pmid:21135504
  36. 36. Ning Y, Zeineldin R, Liu Y, Rosenberg M, Stack MS, Hudson LG. (2005) Down-regulation of integrin alpha2 surface expression by mutant epidermal growth factor receptor (EGFRvIII) induces aberrant cell spreading and focal adhesion formation. Cancer Res. 65(20) 9280–9286. pmid:16230389
  37. 37. Robertson JH, Yang SY, Winslet MC, Seifalian AM. (2009) Functional blocking of specific integrins inhibit colonic cancer migration. Clin Exp Metastasis. 26(7):769–780. pmid:19557530
  38. 38. Gerger A, Hofmann G, Langsenlehner U, Renner W, Weitzer W, Wehrschutz M, et al. (2009) Integrin alpha-2 and beta-3 gene polymorphisms and colorectal cancer risk. Int J Colorectal Dis. 24:159–163. pmid:18836731
  39. 39. Langsenlehner U, Renner W, Yazdani-Biuki B, Eder T, Wascher TC, Paulweber B, et al. (2006) Integrin alpha-2 and beta-3 gene polymorphisms and breast cancer risk. Breast Cancer Res Treat. 97:67–72. pmid:16317580
  40. 40. Schlesselman JJ. (1982) Case-control studies: design, conduct, analysis. Oxford University Press, New York.
  41. 41. Court M: Court Lab Calculator. 2008.
  42. 42. Sole X, Guino E, Valls J, Iniesta R, Moreno V. (2006) SNPStats: a web tool for the analysis of association studies. Bioinformatics. 22:1928–1929. pmid:16720584
  43. 43. Cheng YJ, Hildesheim A, Hsu MM, Chen IH, Brinton LA, Levine PH, et al. (1999) Cigarette smoking, alcohol consumption and risk of nasopharyngeal carcinoma in Taiwan. Cancer Causes Control. 10(3):201–207. pmid:10454065
  44. 44. Armstrong RW, Imrey PB, Lye MS, Armstrong MJ, Yu MC, Sani S. (1998) Nasopharyngeal carcinoma in Malaysian Chinese: salted fish and other dietary exposures. Int J Cancer.77:228–235. pmid:9650558
  45. 45. Pfeifer GP, Denissenko MF, Olivier M, Tretyakova N, Hecht SS, et al. (2002) Tobacco smoke carcinogens, DNA damage and p53 mutations in smoking-associated cancers. Oncogene 21: 7435–7451. pmid:12379884
  46. 46. Moorthy B, Chu C, Carlin DJ. (2015) Polycyclic aromatic hydrocarbons: from metabolism to lung cancer. Toxicol Sci. 145(1):5–15. pmid:25911656
  47. 47. Diggs DL, Huderson AC, Harris KL, Myers JN, Banks LD, Rekhadevi PV, et al. (2011) Polycyuclic aromatic hydrocarbons and digestive tract cancers—a perspective. J Environ Sci Health C Environ Carcinog Ecotoxicol Rev. 29(4):324–357. pmid:22107166
  48. 48. Van Gijssel HE, Schild LJ, Watt DL, Roth MJ, Wang GQ, Dawsey SM, et al. (2004) Polycyclic aromatic hydrocarbon-DNA adducts determined by semiquantitative immunohistochemistry in human esophageal biopsies in 1985. Mutat Res. 547:55–62. pmid:15013699
  49. 49. Wu S, Jiang Y, Yuan J, Zhuang Z, Ke Y. (2009) Association of hOGG1 genotype with lifestyle and oxidative DNA damage among Chinese ethnic populations. Arch Toxicol. 83:663–668. pmid:19350226
  50. 50. Chen J, Liu NN, Li JQ, Yang L, Zeng Y, Zhao XM, et al. (2011) Association between ITGA2 C807T polymorphism and gastric cancer risk. World J Gastroenterol. 17(23):2860–2866. pmid:21734795
  51. 51. Banescu C, Trifa AP, Demain S, Lazar EB, Dima D, Duicu C, et al. (2014) Polymorphism of XRCC1, XRCC3, and XPD Genes and Risk of Chronic Myeloid Leukemia. Biomed Research International. 213790. pmid:24955348
  52. 52. Huang CG, Liu T, Lv GD, Liu Q, Feng JG, Lu X. (2012) Analysis of XPD genetic polymorphisms of esophageal squamous cell carcinoma in a population of Yili Prefecture, in Xinjiang, China. Mol Biol Rep. 39(1): 709–714. pmid:21553048
  53. 53. Long XD, Ma Y, Zhou YF, Yao JG, Ban FZ, Huang YZ, et al. (2009) XPD codon 312 and 751 polymorphisms, and AFB1 exposure, and hepatocellular carcinoma risk. BMC Cancer. 9:400. pmid:19919686
  54. 54. Zhou W, Liu G, Miller DP, Thurston SW, Xu LL, Wain JC, et al. (2003) Polymorphisms in DNA repair genes XRCC1 and ERCC2, smoking, and lung cancer risk. Cancer Epidemiol Biomarkers Prev. 12:359–365. pmid:12692111
  55. 55. Chen S, Tang D, Xue K, Xu L, Ma G, Hsu Y, et al. (2002) DNA repair gene XRCC1 and XPD polymorphisms and risk of lung cancer in Chinese population. Carcinogenesis. 23:599–603.
  56. 56. Hou SM, Ryk C, Kannio A, Angelini S, Falt S, Nyberg F, et al. (2003) Influence of common XPD and XRCC1 variant alleles on p53 mutations in lung tumors. Environmental and molecular mutagenesis. 41(1): 37–42. pmid:12552590
  57. 57. Mechanic LE, Marrogi AJ, Welsh JA, Bowman ED, Khan MA, Enewold L, et al. (2005) Polymorphisms in XPD and TP53 and mutation in human lung cancer. Carcinogenesis. 26(3): 597–604. pmid:15564288
  58. 58. Seker H, Butkiewicz D, Bowman ED, Rusin M, Hedayati M. (2001) Functional significance of XPD polymorphic variants: attenuated apoptosis in human lymphoblastoid cells with the XPD 312 Asp/Asp genotype. Cancer Res. 61: 7430–7434. pmid:11606376
  59. 59. Wang XW, Vermeulen W, Coursen JD, Gibson M, Lupold SE, Forrester K, et al. (1996) The XPB and XPD DNA helicases are components of the p53-mediated apoptosis pathway. Genes Dev. 10: 1219–1232. pmid:8675009
  60. 60. Lin CH, Chen PM, Cheng YW, Chen CY, Yuan CJ, Lee H. (2012) The APE1 Asp/Asp genotype and the combination of APE1 Asp/Asp and hOGG1-Cys variants are associated with increased p53 mutation in non-small cell lung cancer. J Epidemiol. 22(6): 537–542. pmid:23038158
  61. 61. Oren M. (2003) Decision making by p53: life, death and cancer. Cell Death. Differ. 10: 431–442. pmid:12719720
  62. 62. Vogelstein B, Lane D, Levine AJ. (2000) Surfing the p53 network. Nature. 408: 307–310. pmid:11099028
  63. 63. Wang XW, Gibson MK, Vermeulen W, Yeh H, Forrester K, Stiirzbecher HW, et al. (1995) Abrogation of p53-induced apoptosis by the hepatitis B virus X gene. Cancer Research. 55: 6012–6016. pmid:8521383
  64. 64. Smith ML, Seo YR. (2002) p53 regulation of DNA excision repair pathways. Mutagenesis. 17(2): 149–156. pmid:11880544
  65. 65. Smith ML, Chen IT, Zhan Q, O’Connor PM, Fornace AJ Jr. (1995) Involvement of the p53 tumor suppressor in repair of UV-type DNA damage. Oncogene. 10: 1053–1059. pmid:7700629
  66. 66. Kritzik M, Savage B, Nugent DJ, Santoso S, Ruggeri ZM, Kunicki TJ. (1998) Nucleotide polymorphisms in the α2 gene define multiple alleles that are associated with differences in platelet α2β1 density. Blood. 92(7): 2382–2388. pmid:9746778
  67. 67. Varner JA, Cheresh DA. (1996) Integrins and cancer. Curr Opin Cell Biol. 8: 724–730. pmid:8939661
  68. 68. Muller PAJ, Vousden KH. (2013) p53 mutations in cancer. Nature Cell Biology. 15: 2–8. pmid:23263379
  69. 69. Frisch SM, Ruoshlati E. (1997) Integrins and anoikis. Curr Opin Cell Biol. 9: 701–706. pmid:9330874
  70. 70. Stupack DG, Cheresh DA. (2002) Get a ligand, get a life: integrins, signaling and cell survival. Journal of Cell Science. 115: 3729–3738. pmid:12235283
  71. 71. Department of Statistics. (2016). Population by age, sex and ethnic group, 2016. Malaysia.